Ignite Creation Date:
2025-12-24 @ 9:12 PM
Ignite Modification Date:
2025-12-28 @ 10:13 PM
Study NCT ID:
NCT01232504
Status:
COMPLETED
Last Update Posted:
2014-11-04
First Post:
2010-10-25
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Antifugal Effect of Recombinant Human Granulocyte-macrophage Stimulating Factor (rhGM-CSF) in Patients Post Allo-HSCT
Sponsor:
Xiamen Amoytop Biotech Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-09
Start Date Type:
None
Primary Completion Date:
2013-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-06
Completion Date Type:
ACTUAL
First Submit Date:
2010-10-25
First Submit QC Date:
None
Study First Post Date:
2010-11-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-01-26
Results First Submit QC Date:
None
Results First Post Date:
2014-10-27
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-10-27
Last Update Post Date:
2014-11-04
Last Update Post Date Type:
ESTIMATED